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Na,K-ATPase on a waveguide sensor: supramolecular assembly and side directed
binding studies by surface-confmed fluorescence
.
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cSolvias AG, Klybeckstr. 191,4002 Basel, Switzerland
The functional assembly of FITC-Na,K-ATPase membrane fragments on a surface-modified
Ta205 waveguide allows to investigate the directed binding of ligands by surface-confined
fluorescence studies. The results allow to draw conclusions about the sidedness of
interactions. The fluorescence intensity decrease observed upon the selective binding of K+ is
attributed to its coordination to a site accessible from the former intracellular membrane side.
1. INTRODUCTION
The side-directed functional properties of many integral membrane proteins are usuaIly
investigated by solubilizing the protein with detergents for the purpose of reconstitution in
vesicular systems. In order to avoid detergents, a simpler method is desirable where smaIl
amounts of protein containing membrane fragments can directly be assembled in a side-
directed manner on a surface due to supramolecular interactions. Based on sensitive surface-
confined detection techniques, directed binding studies can then be performed. A rea1ization
of this concept (cf. [ 1 ]), consisting of nanoparticulate membrane fragrnents containing the
cardiac glycoside receptor Na,K-A TPase, immobilized on a biocompatible planar waveguide,
is discussed here. The planar arrangement offers the additional advantage that the toPb'faphy
ofthe supramolecular assembly can be characterized by atomic force microscopy (AFM).
2. METHODOLOGY
Biocompatibility ofplanar, 150 nm thick Ta205 waveguides (surface modified with a C16-
phosphate) [2], attached to a 6 J.11 flow cell is achieved by a treatment with phospholipid
vesicles ( 110 nm diameter), prepared by extrusion of 0.7 mM l-palmitoyl-2-oleoyl-
glycerophosphocholine in 10 mM sodium phosphate, 0.02% NaN3, 150 mM NaCI, pH 7.5.
This leads to the formation of a subsequent phospholipid monolayer (Figure la). After buffer
exchange, the membrane fragments are functionally assembled (Figure la) by incubating the
sensor surface with 1.5 J.1M FITC-Na,K-ATPase in 10 mM imidazole/HCI, 100 mM choline
chloride (ChCI) pH 7.5 for 60 min at 20°C, as described in [1]. Purified Na,K-ATPase is
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Figure 1. Schematic illustration ofthe supramolecular assembly ofNa,K-ATPase (protomers)
containing membrane fragments to the biocompatible waveguide surface (two possible
orientations I and II) in a) and ofthe setup for surface-confined fluorescence measurements at
the surface region of the waveguide (the arrow marks the propagating excitation mode); the
waveguide is attached to a flow cell in b ).
isolated from dogfish rectal gland (Squa/u... acanlhias) and pig kidney. The protein is labeled
with FITC according to [3-4]. Fragments can assemble and thus be immobilized in two
possible orientations: former intracellular side up (I) and former extracellular side up (II) in
Figure la). Exchange of solutions is carried out by using a computer controlled pump and
valve system. The fluorescence detection consists of excitation light from an Ar+ laser (488
nm), coupled into the waveguide at a suitable angle of incidence via a diffi-active grating,
which leads to a propagating, evanescent wave field within an about 100 nm thick interface
layer (Figure 1 b ). Only fluorophores located within this wave field are excited and their
emission is monitored employing a high sensitivity photon counting system. Details are given
in [I]. Each step ofthe assembly is separately studied by in sjlu AFM (tapping mode). The
membrane fragment surface coverage ranges between 20 and 50% (Figure 2a).
3. RESULTS AND DISCUSSION
The assembly ofthe FITC-Na,K-A TPase containing fragments leads to an intense and stable
fluorescence signal. The functional properties of the enzyme remain unchanged upon
immobilization, which is concluded from the quantitative comparison of the fluorescence
intensjty changes induced by Ijgand binding under conditions of constant ionic strength with
those observed for the same preparation in solution (both membrane sides acccssible) [1].
Furthermore, the results provide information about the degree of side-directed assembly
(orientation I relative to that ofll in Figure la).
The anti-fluorescein mAb 4-4-20 only quenches the FITC fluorescence in the case of
orientation I because the fluorophore is bound within the A TP binding region at the former
intracellular membrane side. Also phosphorylation with Pi is only possible at this side and
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Figure 2. in silu AFM of dogfish FITC-Na,K-A TPase membrane fragments (bright spots,
height about 12, mean diameter around 250 nm) assembled on the waveguide (with low
resolution, left; bar: 500 nm) and of a part of one large fragment (with high resolution, right;
bar: 50 nm). The dimensions of the particles rising by an average height of 3.9 nm above the
surrounding membrane are indicative ofthe existence ofprotein clusters (~ 10 protomers).
leads to a fluorescence decrease, too. On the other hand, the typical fluorescence intensity
decrease observed in the presence of Mg2+ upon binding of the inhibiting cardiac glycoside
ouabain, known to bind only to a site located at the forrner extracellular membrane side, can
only be expected ifthe corresponding site is accessible in the irnrnobilized state (orientation II
in Figure la). The presence of millimolar concentration of Mg2+ in the Ch+ containing
medium leads to a fluorescence intensity increase even if the ionic strenbYth is maintained.
This increase is not observed in solution. According to AFM studies, this is due to a Mg2+-
induced flattening of the membane frabrrnents by a few nm, possibly as the consequence of a
stronger interaction with the lipid surface. This flattening leads to an increase of the number
of fluorophores located within the evanescent wave field for excitation and thus to the
intensity increase.
For about 7 of a total of 14 complete sets of experiments, the results are interpreted in terms
of an approximatively equal distribution of orientations I and II on the chip. This is deduced
from the observed fluorescence intensity changes which are typical for ligand binding on both
membrane sides. The changes correspond only to about 50% of the ma!,rnitude observed for
the free fra!,'tnents in solution. Details are given in [IJ. However, in the case of 6 sets of
experiments, the fluorescence intensity decrease induced by K+-binding comprises nearly up
to 30% for the dogfish FITC-enzyme and reaches, in contrast to the results described before,
the value observed for the non-immobilized fragments in solution. Spectrofluorometric KCI
titrations in the ChCI containing medium under conditions of constant ionic strength lead to
similar binding constants ofabout S x 103 M-i (stoichiometric coefticient assumed as 1) for
both states of the fragments. After the dissociation of K+ achieved by washing with butTer, the
fluorescence can be quenched upon treatment with the mAb 4-4-20. For fragment assernblies
where such large K+-etTects are observed, the fluorescence change due to the specific
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interaction with ouabain is comparatively small. The latter results suggest that the assernbly
of the fragments is side-directed under these circumstances and corresponds to orientation I in
Figure la). This implies that under these conditions the K+ binding site ofthe FITC-enzyme in
its non-phosphorylated state is accessible frorn the side where the FITC-residue is located,
namely the former intracellular side. If the site were located at the former extracelluiar side,
only a small K+ but a large ouabain effect would have to be expected ( orientation II in Figure
la). The same, unexpected conclusion about the location of the K+ site has also been
suggested frorn experiments with reconstituted FITC-Na,K-ATPase in a vesicular system [5].
The reason why not all assernblies provide a side-directed fragment orientation is not yet
known and may depend on minor differences of waveguide layer properties and
reproducibility of surface modification, fragment preparation and assernbly. Also the
introduction of charges in the phospholipid monolayer has not allowed to derive a conclusive
explanation.
That FITC-Na,K-A TPase membrane fragrnents can be functionally assembled on the
waveguide with the former intracel\ular side oriented upwards is confirmed by AFM. The
height of the protein particles shown in the high resolution AFM of Figure 2b) is consistent
with the expectation for an exposure of the intracel\ular side, which is concluded from the
dimensions resulting from a Iow-resolution 2D-structure deterrnination by electron
crystal\ography [6]. In addition, the particle distribution visible in Figure 2b) implies that the
protein cluster density is higher in the edge region ofthe fragrnent than in its central region.
In summary, the results show that a side-directed supramolecular membrane fragment
assembly is achievable with very small amounts of material. If fluorescence detection can be
applied, the directed binding of ligands to receptor proteins in membranes can be easily
investigated without of isolating individual membrane constituents such as by detergent
treatment, for example. Results about the sidedness of interactions can be obtained
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